Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.
about
New and emerging HDAC inhibitors for cancer treatmentPKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPAEpigenetic upregulation of urokinase plasminogen activator promotes the tropism of mesenchymal stem cells for tumor cells.Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion.Histone deacetylases and cancer.ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapyAcetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity.Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.The role of REST and HDAC2 in epigenetic dysregulation of Nav1.5 and nNav1.5 expression in breast cancer.Metal-dependent Deacetylases: Cancer and Epigenetic RegulatorsNeprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease.Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma.Divergent JNK Phosphorylation of HDAC3 in Triple-Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity.The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.Acetylation is essential for nuclear heme oxygenase-1-enhanced tumor growth and invasiveness.
P2860
Q27022413-EE24860D-8009-4F62-86A1-A2CC9AB042D5Q33818086-DB029FF7-DF50-4BAF-A7CD-4E953080A9EFQ34073304-39B485CC-5791-4E6A-8320-9AAAF40EC0D1Q34146155-82D55798-4A75-4B76-A669-7C94CC11364EQ34298745-9C858E1D-279A-4791-8F88-7587E90B20EFQ34598483-659DD271-BB0C-4C0F-AEC6-C07FB81C0811Q34626608-01161DD8-B813-4F5F-8842-58BEF9710B05Q35911749-7B5950C3-5B99-4863-BA7E-C570DA54F4C3Q36109506-C719353B-13AF-48F3-A23F-1C84F65679CCQ36821154-B6182B1C-7D7F-4ED0-A126-29277EC8AECBQ37294189-84DBF09F-B893-4A48-9B73-F9DB07D67FD8Q38132176-5298AA9E-4260-4713-B237-E901A8ACAA25Q38695555-AC0EDBFF-B562-4195-A147-761B30669B89Q38747135-12CE6D26-296B-4392-BDAA-3D099C638183Q39908636-239004DC-412E-4927-AB55-3E7EF492F42EQ41779392-6EB06970-C576-430A-ACE7-4517644B8316Q46181428-3CCF2C3C-B497-421A-811F-6786F43E3CE4Q46280254-0830B2CF-210A-471E-9CF6-083A9FC84030Q47897624-35E6C8E8-5F3A-45E8-83DA-F3D337980FC7
P2860
Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Inhibition of histone deacetyl ...... okinase plasminogen activator.
@ast
Inhibition of histone deacetyl ...... okinase plasminogen activator.
@en
type
label
Inhibition of histone deacetyl ...... okinase plasminogen activator.
@ast
Inhibition of histone deacetyl ...... okinase plasminogen activator.
@en
prefLabel
Inhibition of histone deacetyl ...... okinase plasminogen activator.
@ast
Inhibition of histone deacetyl ...... okinase plasminogen activator.
@en
P2093
P2860
P356
P1476
Inhibition of histone deacetyl ...... okinase plasminogen activator.
@en
P2093
Bharathi Gorantla
Jasti S Rao
Sai Murali Krishna Pulukuri
P2860
P304
35594-35603
P356
10.1074/JBC.M705867200
P407
P577
2007-10-08T00:00:00Z